Titan Pharmaceuticals Ownership | Who Owns Titan Pharmaceuticals?
Titan Pharmaceuticals Ownership Summary
Titan Pharmaceuticals is owned by 6.70% institutional investors, and 93.30% retail investors. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 0.45% of its assets in Titan Pharmaceuticals shares.
TTNP Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Titan Pharmaceuticals | 6.70% | - | 93.30% |
Sector | Healthcare Stocks | 47.25% | 8.01% | 44.75% |
Industry | Biotech Stocks | 45.35% | 7.81% | 46.83% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Institutional Extnd Mkt Idx Tr | 4.10K | 0.45% | - |
Fidelity Extended Market Index | 3.21K | 0.35% | -182.00 |
Fidelity Nasdaq Composite Index | 963.00 | 0.11% | - |
Fidelity Series Total Market Index | 523.00 | 0.06% | - |
NT Ext Equity Mkt Idx Fd - L | 293.00 | 0.03% | - |
Northern Trust Extended Eq Market Idx | 293.00 | 0.03% | - |
NT Ext Equity Mkt Idx Fd - NL | 161.00 | 0.02% | - |
SSgA U.S. Extended Market Index Class I | 3.10K | 0.02% | - |
State St US Extended Mkt Indx NL Cl C | 155.00 | 0.02% | - |
NT Ext Equity Mkt Idx Fd - DC - NL - T2 | 130.00 | 0.01% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jun 21, 2023 | Lazar David E. | Chief Executive Officer | Sell | $441.65K |
Jun 21, 2023 | Lazar David E. | Chief Executive Officer | Sell | $441.65K |
Jan 25, 2023 | Lazar David E. | Chief Executive Officer | Buy | $20.07K |
Jan 24, 2023 | Lazar David E. | Chief Executive Officer | Buy | $36.22K |
Jul 06, 2022 | Activist Investing LLC | Buy | $739.01K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2023 Q4 | - | - |
2023 Q3 | - | - |
2023 Q2 | - | 2 |
2023 Q1 | 2 | - |
2022 Q3 | 1 | - |
TTNP Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools